Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features

Title
Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 14, Issue 10, Pages 3077-3082
Publisher
American Association for Cancer Research (AACR)
Online
2008-05-16
DOI
10.1158/1078-0432.ccr-07-4743

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started